Research Applications Adipose-Selective Lipolysis Beta-3 adrenergic receptor activation fat breakdown without GHR No IGF-1 Stimulation Clean fat metabolism model no IGF-1, no GHR anabolic confounds vs HGH Fragment 176-191 Tyr modification: stability, bioavailability and potency differences Body Composition Adipose tissue reduction research without systemic GH effects Beta-3 AR Biology Receptor activation, cAMP, HSL phosphorylation, fatty acid release Quick Specs Certificate of Analysis (COA) Frequently Asked Questions How do I reconstitute this peptide
This helps you match the right product to patient needs and identify any contraindications
Dose and frequency depend on your B12 levels and underlying condition
Rotate injection sites (abdomen, thighs, upper arms) to minimize local irritation
in the Journal of Endocrinology and Metabolism reported AOD 9604 to be well-tolerated across tested doses, with no observed alterations in IGF-1 levels, blood glucose, or insulin sensitivity
